Northpointe Capital’s Acadia Healthcare ACHC Stock Holding History

Northpointe Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-200	Closed	-$9K	–	174
2017 Q1	$9K	Sell	200 -6	-3%	-$243	﹤0.01%	172
2016 Q4	$7K	Hold	206	–	–	﹤0.01%	178
2016 Q3	$10K	Hold	206	–	–	﹤0.01%	184
2016 Q2	$11K	Sell	206 -2,692	-93%	-$157K	﹤0.01%	188
2016 Q1	$160K	Sell	2,898 -1,964	-40%	-$112K	0.02%	191
2015 Q4	$322K	Hold	4,862	–	–	0.04%	173
2015 Q3	$322K	Sell	4,862 -1,100	-18%	-$84.6K	0.04%	174
2015 Q2	$467K	Sell	5,962 -47,108	-89%	-$3.39M	0.05%	183
2015 Q1	$3.8M	Sell	53,070 -13,930	-21%	-$893K	0.41%	77
2014 Q4	$4.1M	Sell	67,000 -134,945	-67%	-$7.85M	0.49%	66
2014 Q3	$9.79M	Sell	201,945 -31,960	-14%	-$1.56M	1.04%	24
2014 Q2	$10.6M	Sell	233,905 -49,572	-17%	-$2.18M	1.03%	23
2014 Q1	$12.8M	Sell	283,477 -94,254	-25%	-$4.65M	1.3%	19
2013 Q4	$17.9M	Sell	377,731 -49,508	-12%	-$2.15M	1.58%	9
2013 Q3	$16.8M	Sell	427,239 -128,793	-23%	-$4.78M	1.97%	7
2013 Q2	$18.4M	Buy	+556,032	New	+$18M	2.12%	5

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northpointe Capital's ACHC Position: Q2 2017 in Review

Northpointe Capital sold out of Acadia Healthcare (ACHC) in Q2 2017, closing a stake of 200 shares — an estimated $9K sold.

Northpointe Capital first reported a position in ACHC in Q2 2013 and held it in 16 quarters. The position peaked at $18.4M in Q2 2013. 249 funds tracked by Wall St. Rank hold ACHC as of Q2 2017.

Northpointe Capital reported no remaining Acadia Healthcare position as of Q2 2017 after selling out during the quarter.
Northpointe Capital sold 200 Acadia Healthcare shares in Q2 2017, an estimated $9K.
Northpointe Capital first reported a position in Acadia Healthcare in Q2 2013 and held it in 16 quarters.
Northpointe Capital's Acadia Healthcare position peaked at $18.4M in Q2 2013.
249 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2017.

Based on Northpointe Capital's 13F filing for Q2 2017, filed 3 Aug 2017.